- A. Health Biotechnology
- Areas of activity
- Blood products
- Therapeutic areas
- Musculoskeletal system
- Cardiovascular diseases and circulatory system
- Genetic and rare diseases
- Inflammatory diseases
- Metabolic disorders / Endocrinology
Sobi is an international rare disease company dedicated to providing access to innovative treatments that make a significant difference for people with rare diseases. Sobi is an integrated biotechnology company with in-house capabilities that encompass the entire value chain, from research, to preclinical and clinical development, biologics manufacturing and supply, to patient access and distribution.
We have three business areas: haemophilia, immunology and specialty care. Our research and product portfolio is primarily focused on haemophilia, immunology, and genetic and metabolic diseases.